Roles of STAT3 and ZEB1 Proteins in E-cadherin Down-regulation and Human Colorectal Cancer Epithelial-mesenchymal Transition

Overview

Journal J Biol Chem

Specialty Biochemistry

Date 2011 Dec 30

PMID 22205702

Citations 158

Authors

Hua Xiong

Jie Hong

Wan Du

Yan-Wei Lin

Lin-Lin Ren

Ying-Chao Wang

Wen-Yu Su

Ji-Lin Wang

Yun Cui

Zhen-Hua Wang

Jing-Yuan Fang

Affiliations

Soon will be listed here.

Abstract

The progression of colorectal carcinoma (CRC) to invasive and metastatic disease may involve localized occurrences of epithelial-mesenchymal transition (EMT). However, mechanisms of the EMT process in CRC progression are not fully understood. We previously showed that knockdown of signal transducer and activator of transcription 3 (STAT3) up-regulated E-cadherin (a key component in EMT progression) in CRC. In this study, we examined the roles of STAT3 in CRC EMT and ZEB1, an EMT inducer, in STAT3-induced down-regulation of E-cadherin. Knockdown of STAT3 significantly increased E-cadherin and decreased N-cadherin and vimentin expressions in highly invasive LoVo CRC cells. Meanwhile, overexpression of STAT3 significantly reduced E-cadherin and enhanced N-cadherin and vimentin expressions in weakly invasive SW1116 CRC cells. Activation of STAT3 significantly increased CRC cell invasiveness and resistance to apoptosis. Knockdown of STAT3 dramatically enhanced chemosensitivity of CRC cells to fluorouracil. STAT3 regulated ZEB1 expression in CRC cells, and the STAT3-induced decrease in E-cadherin and cell invasion depended on activation of ZEB1 in CRC cells. Additionally, pSTAT3(Tyr-705) and ZEB1 expressions were significantly correlated with TNM (tumor, lymph node, and metastasis stages) (p < 0.01). In conclusion, STAT3 may directly mediate EMT progression and regulate ZEB1 expression in CRC. ZEB1 may participate in STAT3-induced cell invasion and E-cadherin down-regulation in CRC cells. The expressions of pSTAT3(Tyr-705) and ZEB1 may be positively associated with CRC metastasis. Our data may provide potential targets to prevent and/or treat CRC invasion and metastasis.

Citing Articles

ZEB1 expression in Th17 cells correlated with p-STAT3 in human apical periodontitis.

Sun X, Yang J, Wang Z, Nie Q, Yang Q, Zhang W BMC Oral Health. 2025; 25(1):315.

PMID: 40016707 PMC: 11869427. DOI: 10.1186/s12903-025-05633-y.

L3MBTL3 and STAT3 collaboratively upregulate SNAIL expression to promote metastasis in female breast cancer.

Xiao J, Wang J, Li J, Xiao J, Liu C, Tan L Nat Commun. 2025; 16(1):231.

PMID: 39747894 PMC: 11696420. DOI: 10.1038/s41467-024-55617-9.

Defective N-glycosylation of IL6 induces metastasis and tyrosine kinase inhibitor resistance in lung cancer.

Hung C, Wu S, Yao C, Yeh H, Lin C, Chu C Nat Commun. 2024; 15(1):7885.

PMID: 39251588 PMC: 11385228. DOI: 10.1038/s41467-024-51831-7.

Exosomal miR-106a-5p derived from intermittently hypoxic non-small-cell lung cancer increases tumor malignancy.

Ren J, Jin Z, Huang Y Physiol Rep. 2024; 12(15):e16157.

PMID: 39085755 PMC: 11291016. DOI: 10.14814/phy2.16157.

Methods and computational tools to study eukaryotic cell migration .

Toscano E, Cimmino E, Pennacchio F, Riccio P, Poli A, Liu Y Front Cell Dev Biol. 2024; 12:1385991.

PMID: 38887515 PMC: 11180820. DOI: 10.3389/fcell.2024.1385991.

References

Zhang F, Li C, Halfter H, Liu J . Delineating an oncostatin M-activated STAT3 signaling pathway that coordinates the expression of genes involved in cell cycle regulation and extracellular matrix deposition of MCF-7 cells. Oncogene. 2003; 22(6):894-905. DOI: 10.1038/sj.onc.1206158. View

Luna-Zurita L, Prados B, Grego-Bessa J, Luxan G, Del Monte G, Benguria A . Integration of a Notch-dependent mesenchymal gene program and Bmp2-driven cell invasiveness regulates murine cardiac valve formation. J Clin Invest. 2010; 120(10):3493-507. PMC: 2947227. DOI: 10.1172/JCI42666. View

Sano S, Itami S, Takeda K, Tarutani M, Yamaguchi Y, Miura H . Keratinocyte-specific ablation of Stat3 exhibits impaired skin remodeling, but does not affect skin morphogenesis. EMBO J. 1999; 18(17):4657-68. PMC: 1171539. DOI: 10.1093/emboj/18.17.4657. View

Jeanes A, Gottardi C, Yap A . Cadherins and cancer: how does cadherin dysfunction promote tumor progression?. Oncogene. 2008; 27(55):6920-9. PMC: 2745643. DOI: 10.1038/onc.2008.343. View

Morita Y, Naka T, Kawazoe Y, Fujimoto M, Narazaki M, Nakagawa R . Signals transducers and activators of transcription (STAT)-induced STAT inhibitor-1 (SSI-1)/suppressor of cytokine signaling-1 (SOCS-1) suppresses tumor necrosis factor alpha-induced cell death in fibroblasts. Proc Natl Acad Sci U S A. 2000; 97(10):5405-10. PMC: 25841. DOI: 10.1073/pnas.090084797. View

Spano J, Milano G, Rixe C, Fagard R . JAK/STAT signalling pathway in colorectal cancer: a new biological target with therapeutic implications. Eur J Cancer. 2006; 42(16):2668-70. DOI: 10.1016/j.ejca.2006.07.006. View

Xiong H, Zhang Z, Tian X, Sun D, Liang Q, Zhang Y . Inhibition of JAK1, 2/STAT3 signaling induces apoptosis, cell cycle arrest, and reduces tumor cell invasion in colorectal cancer cells. Neoplasia. 2008; 10(3):287-97. PMC: 2259457. DOI: 10.1593/neo.07971. View

Gan Y, Shi C, Inge L, Hibner M, Balducci J, Huang Y . Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells. Oncogene. 2010; 29(35):4947-58. DOI: 10.1038/onc.2010.240. View

Markowitz S, Dawson D, Willis J, Willson J . Focus on colon cancer. Cancer Cell. 2002; 1(3):233-6. DOI: 10.1016/s1535-6108(02)00053-3. View

10.

Gire V, Roux P, Wynford-Thomas D, Brondello J, Dulic V . DNA damage checkpoint kinase Chk2 triggers replicative senescence. EMBO J. 2004; 23(13):2554-63. PMC: 449769. DOI: 10.1038/sj.emboj.7600259. View

11.

Niwa Y, Kanda H, Shikauchi Y, Saiura A, Matsubara K, Kitagawa T . Methylation silencing of SOCS-3 promotes cell growth and migration by enhancing JAK/STAT and FAK signalings in human hepatocellular carcinoma. Oncogene. 2005; 24(42):6406-17. DOI: 10.1038/sj.onc.1208788. View

12.

Bates R, Mercurio A . The epithelial-mesenchymal transition (EMT) and colorectal cancer progression. Cancer Biol Ther. 2005; 4(4):365-70. DOI: 10.4161/cbt.4.4.1655. View

13.

Gulhati P, Bowen K, Liu J, Stevens P, Rychahou P, Chen M . mTORC1 and mTORC2 regulate EMT, motility, and metastasis of colorectal cancer via RhoA and Rac1 signaling pathways. Cancer Res. 2011; 71(9):3246-56. PMC: 3085654. DOI: 10.1158/0008-5472.CAN-10-4058. View

14.

Vincent T, Neve E, Johnson J, Kukalev A, Rojo F, Albanell J . A SNAIL1-SMAD3/4 transcriptional repressor complex promotes TGF-beta mediated epithelial-mesenchymal transition. Nat Cell Biol. 2009; 11(8):943-50. PMC: 3769970. DOI: 10.1038/ncb1905. View

15.

Joyce T, Cantarella D, Isella C, Medico E, Pintzas A . A molecular signature for Epithelial to Mesenchymal transition in a human colon cancer cell system is revealed by large-scale microarray analysis. Clin Exp Metastasis. 2009; 26(6):569-87. DOI: 10.1007/s10585-009-9256-9. View

16.

Peinado H, Olmeda D, Cano A . Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?. Nat Rev Cancer. 2007; 7(6):415-28. DOI: 10.1038/nrc2131. View

17.

Arias A . Epithelial mesenchymal interactions in cancer and development. Cell. 2001; 105(4):425-31. DOI: 10.1016/s0092-8674(01)00365-8. View

18.

Hay E . An overview of epithelio-mesenchymal transformation. Acta Anat (Basel). 1995; 154(1):8-20. DOI: 10.1159/000147748. View

19.

Makrilia N, Kollias A, Manolopoulos L, Syrigos K . Cell adhesion molecules: role and clinical significance in cancer. Cancer Invest. 2009; 27(10):1023-37. DOI: 10.3109/07357900902769749. View

20.

Bhowmick N, Ghiassi M, Bakin A, Aakre M, Lundquist C, Engel M . Transforming growth factor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. Mol Biol Cell. 2001; 12(1):27-36. PMC: 30565. DOI: 10.1091/mbc.12.1.27. View